View Cart (0)
  • About
  • Academies
  • Heart Failure Guide
  • What We Do
  • Get involved
  • Shop
  • Patient Educators

Novartis



Tag: Novartis

Sep 5

LCZ696 (sacubitril valsartan) available to NHS through EAMS

Posted by NickUncategorized

LCZ696 (sacubitril valsartan) available to NHS through EAMS New heart failure medicine LCZ696 (sacubitril valsartan) is to be made available to the NHS under the Early Access to Medicines Scheme […]

Read More
Jul 8

What is Entresto?

Posted by NickHeart failure charity

What is Entresto? What is Entresto? , it sounds like a Superhero Comic character, formally called LCZ696 is a blockbuster success but only time will tell. The biggest challenge for […]

Read More
Jul 8

Novartis Entresto approval by the FDA

Posted by Sam Redmond-LyonHeart failure treatment

Novartis Entresto approval by the FDA Novartis new heart failure medicine LCZ696, now called Novartis Entresto approved by the FDA to reduce risk of cardiovascular death and heart failure hospitalisation […]

Read More
May 23

EU Health Regulators Reject Serelaxin

Posted by NickHeart failure patient information

EU health regulators have recommended against approving Novartis’s experimental heart failure drug for the second time this year due to insufficient evidence it improves symptoms, the Swiss drugmaker said in […]

Read More
May 17

FDA reject Serelaxin

Posted by NickHeart failure patient information

U.S. health regulator the at the FDA turned down an application to approve Novartis‘ experimental heart failure drug due to insufficient evidence that it improves symptoms, Novartis said. Novartis said in […]

Read More
Mar 31

Novartis rebound from Serelaxin setback

Posted by NickHeart failure patient information

Novartis rebound from Serelaxin setback  Novartis announced today that the Data Monitoring Committee (DMC) unanimously recommended early closure of the PARADIGM-HF study, indicating patients with chronic heart failure with reduced […]

Read More
Mar 25

Another hurdle for Serelaxin

Posted by NickHeart failure patient information

Another hurdle for Serelaxin  In advance of an upcoming advisory committee meeting, the FDA in-house review says point blank that the application for the heart drug serelaxin should be rejected […]

Read More
Sep 18

Heart Failure and glass slippers

Posted by NickHeart failure charity, Heart failure treatment

Heart Failure and glass slippers  Heart failure is the ultimate “Cinderella Syndrome” but just recently Prince Charming (Pharma and Biotechs) maybe offering that glass slipper. New treatments for heart failure […]

Read More
Sep 3

Serelaxin proves to be effective across all Heart Failure patient groups

Posted by NickHeart failure treatment

Serelaxin proves to be effective across all Heart Failure patient groups As a charity we think this is a very important breakthrough in drug treatment for sufferers of heart failure. […]

Read More
Jun 25

New drug on the horizon

Posted by NickHeart failure treatment

New drug on the horizon  It’s all very exciting at the moment as there seems to be a new line of drugs coming through trials that seem to have a […]

Read More

Posts navigation

Older posts

Blog Categories

  • Competitions and Giveaways
  • Exercise and diet
  • Heart failure
  • Heart failure carers
  • Heart failure charity
  • Heart failure diagnostics
  • Heart failure fundraising
  • Heart failure patient information
  • Heart failure patient support
  • heart failure policy
  • Heart failure symptons
  • Heart failure treatment
  • Heart News
  • How the heart works
  • Marvellous Awards
  • Patient News
  • Press Release
  • Research and Clinical Trials
  • Self Management
  • Uncategorized
  • What is heart failure


Pumping Marvellous Foundation
  • About
  • Academies
  • Heart Failure Guide
  • What We Do
  • Get involved
  • Shop
  • Patient Educators
  • Contact

Pumping Marvellous Foundation, Suite 111 Business First, Millennium City Park, Millennium City Road, Preston, UK, PR2 5BL
Registered Charity Number 1151848

Policies on our website

1.The content in this website should not replace and/or substitute the interactions with and advice you get from your healthcare professional, and if you have any concerns about your condition you should discuss these with your healthcare professional at the earliest opportunity.

2.This website uses cookies to improve your experience.

We'll assume you're ok with this.
Accept Reject Read More

Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT